Publications
Project Data Sphere’s success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| AUTHOR(S) | DATE | ARTICLE TITLE | JOURNAL |
|---|---|---|---|
| Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O'Brien, Paul Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo H. Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava | Apr-23 | Case Studies for Overcoming Challenges in Using Big Data in Cancer | Cancer Research |
| Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O'Brien, Paul Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo H. Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava | Apr-23 | Challenges to Using Big Data in Cancer | Cancer Research |
| Daniel Caldeira, Beatriz Nogueira-Garcia, Ana Abreu & Fausto J. Pinto | Dec-22 | Fish intake and risk of cardiovascular events: an analysis of the VITAL cohort | European Journal of Clinical Nutrition |
| Yifei Sun, Xuming He, Jianhua Hu | Dec-22 | An omnibus test for detection of subgroup treatment effects via data partitioning | Annals of Applied Statistics |
| Saskia Litière, Jan Bogaerts | Nov-22 | Imaging endpoints for clinical trial use: a RECIST perspective | Journal for ImmunoTherapy of Cancer |
| Quentin Le Coënt, Catherine Legrand, Virginie Rondeau | Nov-22 | Time-to-event surrogate endpoint validation using mediation analysis and meta-analytic data | Biostatistics |
| Austin L. Johnson, Michael Anderson, Max Bouvette, Israel Pinero, Shelby Rauh, Bradley Johnson, Micah Kee, Benjamin Heigle, Andrea C. Tricco, Matthew J. Page, Patti McCall Wright, Matt Vassar | Nov-22 | Clinical Trial Data-sharing Policies Among Journals, Funding Agencies, Foundations, and Other Professional Organizations: A Scoping Review | Journal of Clinical Epidemiology |
| Celine Yeh, Mengxi Zhou, Keith Sigel, Gayle Jameson, Ruth White, Rachael Safyan, Yvonne Saenger, Elizabeth Hecht, John Chabot, Stephen Schreibman, Béata Juzyna, Marc Ychou, Thierry Conroy, Tito Fojo, Gulam A Manji, Daniel Von Hoff, Susan E Bates | Nov-22 | Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data | The Oncologist |
| Jian-Sin Lee, Wei Jeng | Oct-22 | Integrated but Isolated: Implications from a Systematic Review of the Access Control Ecosystem for Individual Participant Data in Clinical Studies | John Wiley & Sons, Ltd (asis&t) |
| Zihang Zhong, Min Yang,Senmiao Ni, Lixin Cai,Jingwei Wu, Jianling Bai | Oct-22 | The heterogeneity effect of surveillance intervals on progression free survival | Journal of Applied Statistics |
| Khaled El Emam, Lucy Mosquera, Xi Fang | Oct-22 | Validating a membership disclosure metric for synthetic health data | Jamia Open |
| J. C. Angulo, J. P. Ciria Santos, A. Gómez-Caamaño, R. Poza de Celis, J. L. González Sala, J. M. García Garzón, J. A. Galán-Llopis, M. Pérez Sampietro, V. Perrot & J. Planas Morin on behalf of ANARESISTANCE study group | Sep-22 | Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study | SpringerLink |
| Qiyu Wang, Ian A. Strohbehn, Sophia Zhao, Harish Seethapathy, Samuel D. Strohbehn, Paul Hanna, Meghan Lee, Riley Fadden, Ryan J. Sullivan, Genevieve M. Boland, Kerry L. Reynolds, Meghan E. Sise | Aug-22 | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma | ScienceDirect |
| Amita Puranik, Prajakta Dandekar, Ratnesh Jain | Aug-22 | Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals | AIChE Biotechnology Progress |
| Gerd Rippin, Nicolás Ballarini, Héctor Sanz, Joan Largent, Chantal Quinten & Francesco Pignatti | Jul-22 | A Review of Causal Inference for External Comparator Arm Studies | Springer Nature Switzerland AG |
| Daniele Modonutti MD,Sami E. Majdalany MD,Nicholas Corsi BS,Pin Li PhD,Akshay Sood MD,Deepansh Dalela MD,Marcus L. Jamil MD,Clara Hwang MD,Mani Menon MD,Craig G. Rogers MD,Quoc-Dien Trinh MD,Giacomo Novara MD,Firas Abdollah MD | Jul-22 | A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis | The Prostate |
| Jue Hou, Rachel Zhao, Tianrun Cai | Jun-22 | Temporal Trends in Clinical Evidence of 5-Year Survival Within Electronic Health Records Among Patients With Early-Stage Colon Cancer Managed With Laparoscopy-Assisted Colectomy vs Open Colectomy | JAMA Network Open |
| Garrett S Bullock,Patrick Ward,Scott Peters, Amelia Joanna Hanford Arundale , Andrew Murray,Franco M Impellizzeri, Stefan Kluzek | Jun-22 | Call for open science in sports medicine | British Journal of Sports Medicine |
| Sophia Z. Shalhout, Kevin S. Emerick, Howard E. Kaufman, David M. Miller | Jun-22 | A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma | Journal of Clinical Oncology |
| Chongyang Duan,Ao Yuan &Ming T. Tan | May-22 | Robust estimates of regional treatment effects in multiregional randomized clinical trials with ordinal responses | Journal of Biopharmaceutical Statistics |
| Jiang Y, Cai D, Shi S | Apr-22 | Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies | Dovepress |
| Tomohiro Ohigashi, Kazushi Maruo, Takashi Sozu, Masahiko Gosho | Apr-22 | Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials | Sage Journals |
| Hiroyuki Saeki, Takuji Komeda, Risa Tanaka, Yuki Yamatani & Hironori Sakai | Mar-22 | Estimation of a Suitable Number of Patients for Selective Safety Data Collection (ICH E19 Draft Guideline): When is the Safety Profile of a Drug Well Characterized? | Therapeutic Innovation & Regulatory Science |
| T.Elumalai, C.Barker, T.Elliott, J.Malik, A.Tran, A.Hudson, Y.P.Song, K.Patel, J.Lyons, P.Hoskin, A.Choudhury, H.Mistry | Mar-22 | Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel | Clinical Oncology |
| Steffen Ventz, Sean Khozin, Bill Louv, Jacob Sands, Patrick Y. Wen, Leah Comment, Brian M. Alexander, Lorenzo Trippa | Mar-22 | The Design and Evaluation of Hybrid Controlled Trials that Leverage External Data and Randomization | Research Square |
| Siddharth Ramchandran, Gleb Tikhonov, Otto Lönnroth, Pekka Tiikkainen, Harri Lähdesmäki | Mar-22 | Learning Conditional Variational Autoencoders with Missing Covariates | arXiv |
| Ahmad Y. Abuhelwa, Sarah Badaoui, Hoi-Yee Yuen, Ross A. McKinnon, Warit Ruanglertboon, Kiran Shankaran, Anniepreet Tuteja, Michael J. Sorich & Ashley M. Hopkins | Feb-22 | A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma | Cancer Chemotherapy and Pharmacology |
| Saki Nishiyama, Mamoru Narukawa | Feb-22 | Impact of the Economic Status of the Patient's Country of Residence on the Outcome of Oncology Clinical Trials | The Oncologist |
| Deborah Plana, Geoffrey Fell, Brian M. Alexander, Adam C. Palmer & Peter K. Sorger | Feb-22 | Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications |
| Liling Huang , Shiyu Jiang & Yuankai Shi | Feb-22 | Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data | futuremedicine |
| Yu, Peter MD, ET AL | Feb-22 | Artificial Intelligence Comes of Age in the Fight Against Cancer | Oncology Times |
| Fadi S.Dahdaleh, Scott K.Sherman, Hunter D.D.Witmer, Ankit Dhiman, Rahul Rajeev, Elizabeth C.Poli, Fabian M.Johnston, Kiran K.Turagaa | Jan-22 | Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581 | The American Journal of Surgery |
| Sophia Z Shalhout, Farees Saqlain, Kayla Wright, Oladayo Akinyemi, David M Miller | Jan-22 | Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry | Jamia Open |
| Xiang Yin, Pallavi S. Mishra-Kalyan, Rajeshwari Sridhara, Mark D. Stewart,Elizabeth A. Stuart, and Ruthanna C. Davi | Jan-22 | Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer | Journal of Biopharmaceutical Statistics |
| Kirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, Oleg Stepanov, Nataliya Kudryashova, Gabriel Helmlinger, Kirill Peskov | Jan-22 | A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics | ASCPT |
| Jie Zhou, Xun Jiang, Hong Amy Xia, Peng Wei, Brian P. Hobbs | Dec-21 | Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response | Statistics in Medicine |
| Shiyu Jiang, Liling Huang, Hongnan Zhen, Peijie Jin, Jing Wang & Zhihuang Hu | Dec-21 | Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis | BMC Cancer |
| Anne A. Eaton, Emily C. Zabor | Dec-21 | Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules | Statistics in Medicine |
| Leeann B Burton, Mahsa Eskian, Amanda C Guidon, Kerry L Reynolds | Nov-21 | A review of neurotoxicities associated with immunotherapy and a framework for evaluation | Neuro-Oncology Advances |
| Giorgos Bakoyannis, Dipankar Bandyopadhyay | Nov-21 | Nonparametric tests for multistate processes with clustered data | AISM |
| Fionán Donohoea, Yvonne O'Mearaa, AidinRoberts, Louise Comerford, Catherine M. Kelly, JaniceM. Walshe, Michelle Peate, Marth aHickey, Donal J.Brennan | Nov-21 | The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study | Contemporary Clinical Trials Communications |
| Ran Zeng, Fang Liu, Chen Fang, Jin Yang, Lifeng Luo, Ping Yue, Beili Gao, Yuchao Dong, and Yi Xiang | Oct-21 | PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients | Frontiers in Immunology |
| Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes-Rivera, Mei-Yin C Polley, Fahar Merchant, Lauren E Abrey, Joshua E Allen, Laura K Aguilar, Estuardo Aguilar-Cordova, David Arons, Kirk Tanner, Stephen Bagley, Mustafa Khasraw, Prof Timothy Cloughesy, Prof Patrick Y Wen, Brian M Alexander, Lorenzo Trippa | Sep-21 | Leveraging external data in the design and analysis of clinical trials in neuro-oncology | Lancet Oncology |
| Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi,Michael Weller, Amy B. Heimberger | Sep-21 | Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma | American Association for Cancer Research |
| Enrique Vazquez, Henri Gouraud, Florian Naudet, Cary P Gross, Harlan M Krumholz, Joseph S Ross, Joshua D Wallach | Aug-21 | Characteristics of available studies and dissemination of research using major clinical data sharing platforms | Clinical Trials |
| Olutomilayo Olayemi Petinrin; Xiangtao Li; Ka-Chun Wong | Aug-21 | Particle Swarm Optimized Gaussian Process Classifier for Treatment Discontinuation Prediction in Multicohort Metastatic Castration-Resistant Prostate Cancer Patients | IEEE Journal of Biomedical and Health Informatics |
| Hirotaka Miyashita, Christina Cruz, Vaibhav Patel | Aug-21 | Risk factors of skeletal-related events in patients with bone metastatic castration-resistant prostate cancer undergoing treatment with zoledronate | Supportive Care in Cancer |
| Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Teilo H Schaller, Anthony A Amato, Allison Betof Warner, Priscilla K Brastianos, Tracey A Cho, Stacey L Clardy, Justine V Cohen, Jorg Dietrich, Michael Dougan, Christopher T Doughty, Divyanshu Dubey, Jeffrey M Gelfand, Jeffrey T Guptill, Douglas B Johnson, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Jenny Linnoila, Andrew L Mammen, Maria Martinez-Lage, Meghan J Mooradian, Jarushka Naidoo, Tomas G Neilan, David A Reardon, Krista M Rubin, Bianca D Santomasso, Ryan J Sullivan, Nancy Wang, Karin Woodman, Leyre Zubiri, William C Louv, Kerry L Reynolds | Jul-21 | Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors | Journal for ImmunoTherapy of Cancer |
| Takuma Oda, Shih-Wei Chiu, Takuhiro Yamaguchi | Jul-21 | Semi-automated Conversion of Clinical Trial Legacy Data into CDISC SDTM Standards Format Using Supervised Machine Learning | Methods of Information in Medicine |
| Aakanksha Khandelwal, Mace Rothenberg, Sean Khozin, Amanda C Guidon, Michael Dougan, Leyre Zubiri, Laura Petrillo, Meghan E Sise, Alexandra-Chloe Villani, Douglas B Johnson, Osama Rahma and Elad Sharon | Jul-21 | Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data | Journal for ImmunoTherapy of Cancer |
| Geoffrey Fell, Robert A Redd, Alyssa M Vanderbeek, Rifaquat Rahman, Bill Louv, Jon McDunn, Andrea Arfè, Brian M Alexander, Steffen Ventz, Lorenzo Trippa | Jun-21 | KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials | Database |
| Mustafa Hashmi , Jeremy Rassen & Sebastian Schneeweiss | Jun-21 | Single-arm oncology trials and the nature of external controls arms | Journal of Comparative Effectiveness Research |
| Michael J. Kane | Jun-21 | Towards a Grammar for Processing Clinical Trial Data | R Journal Volume |
| Shalhout, Sophia Z.; Kaufman, Howard L.; Sullivan, Ryan J.; Lawrence, Donald; Miller, David M. | Jun-21 | Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series | Journal of Immunotherapy |
| Steffen Ventz, PhD, Leah Comment, PhD, Bill Louv, PhD, Rifaquat Rahman, MD, Patrick Y Wen, MD, Brian M Alexander, MD, Lorenzo Trippa, PhD | Jun-21 | The Use of External Control Data for Predictions and Futility Interim Analyses in Clinical Trials | Neuro-Oncology |
| Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James M Hillis, Teilo Schaller, Kerry Lynn Reynolds, Neuro irAE Disease Definition Panel | May-21 | Consensus disease definitions for the spectrum of neurologic immune related adverse events | Journal of Clinical Oncology |
| Felix D. Beacher, Lilianne R. Mujica-Parodi , Shreyash Gupta and Leonardo A. Ancora | May-21 | Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer | Algorithms |
| Ganessan Kichenadasse MBBS, FRACP, John O. Miners PhD, Arduino A. Mangoni MBBS, PhD, FRACP, Christos S. Karapetis MBBS, FRACP, Ashley M. Hopkins PhD and Michael J. Sorich PhD | May-21 | Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy | Journal of the National Comprehensive Cancer Network |
| Kelsey H Natsuhara, Li Zhang, Christopher A Carlos, Hala T Borno | Apr-21 | Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study | Journal of Onco-Nephrology |
| Wei-Xiang Qi, Yi Xiang, Shengguang Zhao & Jiayi Chen | Apr-21 | Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab | Cancer Immunology, Immunotherapy |
| Eric V.Li, Mohammad R.Siddiqui, Adam B.Weiner, Anna E.Prizment, Charles J.Ryan, Alicia K.Morgans | Mar-21 | Efficacy and adverse events of docetaxel for metastatic, hormone-sensitive prostate cancer among elderly men: post-hoc analysis of CHAARTED trial | Clinical Genitourinary Cancer |
| Zahra Azizi, Chaoyi Zheng, Lucy Mosquera, Louise Pilote, Khaled El Emam, GOING-FWD Collaborators Correspondence to Dr Khaled El Emam; kelemam@ehealthinformation.ca | Mar-21 | Can synthetic data be a proxy for real clinical trial data? A validation study | BMJ Open |
| Kentaro Matsuura, Jun Tsuchida, Shuji Ando, Takashi Sozu | Mar-21 | Matrix decomposition in meta‐analysis for extraction of adverse event pattern and patient‐level safety profile | Pharmaceutical Statistics |
| Jean Coquet, PhD; Nicolas Bievre, MS; Vincent Billaut, MS; Martin Seneviratne, MD; Christopher J. Magnani, MPhil; Selen Bozkurt, PhD; James D. Brooks, MD; Tina Hernandez-Boussard, PhD | Feb-21 | Assessment of a Clinical Trial–Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer | JAMA Network Open |
| L. Du, C. Yau, L. Brown-Swigart, R. Gould, G. Krings, G. L. Hirst, I. Bedrosian, R. M. Layman, J.M. Carter, M. Klein, S. Venters, S. Sonal, M. van der Noordaa, A. J. Chien, T. Haddad, C. Isaacs, L. Pusztai, K. Albain, R. Nanda, D. Tripathy, M.C. Liu, J. Boughey, R. Schwab, N. Hylton, A.DeMichele, J. Perlmutter, D. Yee, D. Berry, L. van’t Veer, V. Valero, L. Esserman, W. F.Symmans | Feb-21 | Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer prior to chemo-endocrine therapy | Annals of Oncology |
| Jiawei Zhou, Quefeng Li, Yanguang Cao | Feb-21 | Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer | Cancer Research |
| Alberto Martini, Anish B. Parikh, John P. Sfakianos, Francesco Montorsi, Matthew D. Galsky, William K. Oh, Che-Kai Tsao | Feb-21 | Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data | Prostate Cancer and Prostatic Diseases |
| Sophia Z.Shalhout, PhD; Jong ChulPark, MD; Kevin S.Emerick,MD; Ryan J.Sullivan, MD; Howard L.Kaufman, MD; David M.MillerMD, PhD | Jan-21 | Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma | Journal of the American Academy of Dermatology |
| Lixia Wu, Lina Zhu, Kequn Xu, Siyuan Zhou, Yang Zhou, Tiening Zhang, Junjie Hang, Benny Chung-Ying Zee | Jan-21 | Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data | Journal of Cancer |
| Krastan B. Blagoev, Roumen Iordanov, Mengxi Zhou, Tito Fojo, Susan E. Bates | Jan-21 | Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer | Oncotarget |
| Steven B.Cohen, Jennifer Unangst, Feng Yu | Nov-20 | Enhancing the analytic utility of clinical trial data to inform health disparities research | Contemporary Clinical Trials Communications |
| Khaled El Emam, Lucy Mosquera, Chaoyi Zheng | Nov-20 | Optimizing the synthesis of clinical trial data using sequential trees | Journal of the American Medical Informatics Association |
| CEO Roundtable on Cancer | Nov-20 | Merck KGaA, Darmstadt, Germany, Recognized for Collaborative Cancer Research by CEO Roundtable on Cancer | PR Newswire |
| Aurélie Lombard, Hitesh Mistry, Leon Aarons, Kayode Ogungbenro | Oct-20 | Dose individualisation in oncology using chemotherapy‐induced neutropenia: Example of docetaxel in non‐small cell lung cancer patients | British Journal of Clinical Pharmacology |
| Farees Saqlain, Sophia Z. Shalhout, Kevin S. Emerick, Tomas G. Neilan, Tatyana Sharova, David Michael Miller | Sep-20 | Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events | Case Reports in Dermatological Medicine |
| Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller | Sep-20 | Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis | Case Reports in Oncological Medicine |
| Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller | Sep-20 | Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis | Case Reports in Oncological Medicine |
| Hirotaka Miyashita, Christina Cruz, Cardinale Smith | Aug-20 | Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate—a post hoc analysis of a randomized clinical trial | Supportive Care in Cancer |
| Theresa Wizemann, Eeshan Khandekar, Jennifer Hinners, Carolyn Shore | Jul-20 | Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop (2020) | National Academies Press |
| G. Sonpavde, G. R. Pond, A. J. Templeton, E. D. Kwon, J.S. De Bono | Jun-20 | Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer | Prostate Cancer and Prostatic Diseases |
| Omar Abdel-Rahman | Jun-20 | Impact of Baseline Characteristics on Extensive-stage SCLC Patients Treated with Etoposide/Carboplatin; a Secondary Analysis of a Phase III Study | The Clinical Respiratory Journal |
| Hirotaka Miyashita, Christina Cruz, Stephen Malamud | May-20 | Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate | Breast Cancer Research and Treatment |
| Chun Pan, Bo Cai, Lianming Wang | May-20 | A Bayesian approach for analyzing partly interval-censored data under the proportional hazards model | Statistical Methods in Medical Research |
| Warit Ruanglertboon, Michael J. Sorich, Andrew Rowland, Ashley M. Hopkins | May-20 | Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients | International Journal of Clinical Oncology |
| Omar Abdel-Rahman, Hatim Karachiwala, Jacob C. Easaw | May-20 | Outcomes of Patients With Advanced Gastrointestinal Cancer in Relationship to Opioid Use: Findings From Eight Clinical Trials | Journal of the National Comprehensive Cancer Network |
| Alberto Martini, John Pfail, Francesco Montorsi, Matthew D. Galsky, William K. Oh | Apr-20 | Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial | Prostate Cancer and Prostatic Diseases |
| Omar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski | Mar-20 | Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trials | Journal of Cancer Research and Clinical Oncology |
| Anish B. Parikh, Alberto Martini, John Sfakianos, Matt D. Galsky, William K. Oh, Che-Kai Tsao | Feb-20 | Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data | Journal of Clinical Oncology |
| Omar Abdel‐Rahman, S. Ghosh, and J. Walker | Feb-20 | Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials | Clinical and Translational Oncology |
| Kaiwen Deng, Hongyang Li, and Yuanfang Guan | Feb-20 | Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning | iScience |
| Wei-xiang Qi, Lu Cao, Cheng Xu, Shengguang Zhao, Jiayi Chen | Feb-20 | Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials | The Breast |
| Mika Murtojarvia, Anni S. Halkolab, Antti Airolaa, Teemu D. Laajala, Tuomas Mirttid, Tero Aittokalliob, Tapio Pahikkalaa | Jan-20 | Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasets | International Journal of Medical Informatics |
| Timothe Menard, Bjorn Koneswarakantha, Donato Rolo, Yves Barmaz, Leszek Popko, Rich Bowling | Dec-19 | Follow‑Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under‑Reporting in Oncology Trials? | Drug Safety |
| Justyna Mierzynska, Mekdes Taye, Madeline Pe, Corneel Coens, Francesca Martinelli, Katarzyna Pogoda, Galina Velikova, Vesna Bjelic-Radisic, Fatima Cardoso, Etienne Brain, Michail Ignatiadis, Martine Piccart, Geertjan Van Tienhoven, Robert Mansel, Hans Wildiers, Andrew Bottomley, on behalf of EORTC and EORTC Breast Cancer Group | Dec-19 | Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer | European Journal of Cancer |
| Omar Abdel-Rahman | Dec-19 | Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials | Clinical Colorectal Cancer |
| Omar Abdel-Rahman | Nov-19 | ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials | International Journal of Colorectal Disease |
| Jiawei Zhou, Yutong Liu, Yubo Zhang, Quefeng Li and Yanguang Cao | Nov-19 | Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer; a retrospective analysis | American Association for Cancer Research |
| Omar Abdel-Rahman | Oct-19 | Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel - A pooled analysis of 3 randomized studies | Urologic Oncology: Seminars and Original Investigations |
| Wei-xiang Qi, Shengguang Zhao, and Jiayi Chen | Oct-19 | Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment | Future Oncology |
| Tobias Klatte, Kevin M. Gallagher, Luca Afferi, Alessandro Volpe, Nils Kroeger, Silvia Ribback, Alan McNeill, Antony C. P. Riddick, James N. Armitage, Tevita F. Aho, Tim Eisen, Kate Fife, Axel Bex, Allan J. Pantuck, Grant D. Stewart | Oct-19 | The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort | BMC Medicine |
| Louis Dron, Shirin Golchi, Grace Hsu, Kristian, Thorlund | Sep-19 | Minimizing Control Group Allocation in Randomized Trials Using Dynamic Borrowing of External Control Data – An Application to Second Line Therapy for Non-Small Cell Lung Cancer | Contemporary Clinical Trials Communications |
| Omar Abdel-Rahman | Sep-19 | Outcomes of metastatic breast cancer patients in relationship to disease‐free interval following primary treatment of localized disease; a pooled analysis of two clinical trials | The Breast Journal |
| Toby Wilkinson, Siddharth Sinha, Niels Peek and Nophar Geifman | Aug-19 | Clinical trial data reuse – overcoming complexities in trial design and data sharing | Trials |
| Omar Abdel-Rahman | Jun-19 | Asian Americans have better outcomes of non-metastatic gastric cancer compared to other United States racial groups: A secondary analysis from a randomized study | World Journal of Gastrointestinal Oncology |
| Omar Abdel-Rahman and Hatim Karachiwala | Jun-19 | Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials | International Journal of Colorectal Disease |
| Mehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, Outi Hirvonen, Sirkku Jyrkkio, Laura L. Elo | May-19 | A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer | F1000 Research |
| Paul Germonpré, Tim Van den Wyngaert and Conteporary Clinical Trials authors are: Louis Dron, Shirin Golchi, Grace Hsu, Kristian Thorlund | Apr-19 | Second-Line Erlotinib After Failure of Pemetrexed-Containing Chemotherapy in Advanced non-Small Cell Lung Cancer (NSCLC): Real-World Effectiveness, Safety and Tolerability | PLOS ONE |
| Hitesh B. Mistry, Gabriel Helmlinger, Nidal Al-Huniti, Karthick Vishwanathan, James Yates | Apr-19 | Resistance Models to EGFR Inhibition and Chemotherapy in Non-Small Cell Lung Cancer Via Analysis of Tumour Size Dynamics | Cancer Chemotherapy and Pharmacology |
| Omar Abdel-Rahman | Mar-19 | Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials | Clinical Colorectal Cancer |
| Omar Abdel-Rahman | Mar-19 | Comparison of outcomes of radiotherapy-treated localized prostate cancer patients within a clinical trial setting versus real-life setting | Future Oncology |
| Tao Wang, Rong Lu, Sunny Lai, Joan H. Schiller, Fang Liz Zhou, Bo Ci, Stacy Wang, Xiaohan Gao, Bo Yao, David E. Gerber, David H. Johnson, Guanghua Xiao, Yang Xie | Feb-19 | Development and Validation of a Nomogram Prognostic Model for Patients with Advanced Non-Small-Cell Lung Cancer | Cancer Informatics |
| Omar Abdel-Rahman | Feb-19 | Impact of Diabetes on the Outcomes of Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel: A Pooled Analysis of Three Phase III Studies | Clinical Genitourinary Cancer |
| Michael A. Webster-Clark, Hanna K. Sanoff, Til Stürmer, Sharon Peacock Hinton, Jennifer L. Lund | Jan-19 | Diagnostic Assessment of Assumptions for External Validity - An Example Using Data in Metastatic Colorectal Cancer | Epidemiology |
| Omar Abdel-Rahman and Osama Ahmed | Jan-19 | Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer | International Journal of Colorectal Disease |
| Omar Abdel-Rahman | Dec-18 | Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients with Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized Trials | Clinical Colorectal Cancer |
| Omar Abdel-Rahman | Dec-18 | Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials | Clinical Breast Cancer |
| Omar Abdel-Rahman | Dec-18 | Statin Treatment and Outcomes of Metastatic Pancreatic Cancer: A Pooled Analysis of Two Phase III Studies | Clinical and Translational Oncology |
| Omar Abdel-Rahman | Dec-18 | 5-Fluorouracil-Related Cardiotoxicity; Findings from Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer | Clinical Colorectal Cancer |
| Omar Abdel-Rahman, Winson Y.Cheung | Dec-18 | Impact of Prior Local Treatment on the Outcomes of Metastatic Hormone-Sensitive Prostate Cancer: Secondary Analysis of a Randomized Controlled Trial | Clinical Genitourinary Cancer |
| Kaitlyn Johnson, Axel Gomez, Jackson Burton, Douglas White, Arijit Chakravarty, Annette Schmid, Dean Bottino | Nov-18 | Directional Inconsistency Between Response Evaluation Criteria in Solid Tumors (RECIST) Time to Progression and Response Speed and Depth | European Journal of Cancer |
| Mel Horwitch, Milos Milicsevics | Oct-18 | Incumbent Firm Capacity Building in Analytics: Strategy, Structure, and Innovation Management Perspectives | IEEE Journal of Biomedical and Health Informatics |
| Fadi S. Dahdaleh, Scott K. Sherman, Elizabeth C. Poli, Janani Vigneswaran, Blase N. Polite, Manish R. Sharma, Daniel V. Catenacci, Steven B. Maron, Kiran K. Turaga | Oct-18 | Obstruction Predicts Worse Long-term Outcomes in Stage III Colon Cancer: A Secondary Analysis of the N0147 Trial | Surgery |
| Jeffrey West, Yongqian Ma, Paul K. Newton | Oct-18 | Capitalizing on Competition: An Evolutionary Model of Competitive Release in Metastatic Castration Resistant Prostate Cancer Treatment | Journal of Theoretical Biology |
| Stephen B. Cohen, Jennifer Unangst | Sep-18 | Data Integration Innovations to Enhance Analytic Utility of Clinical Trial Content to Inform Health Disparities Research | Frontiers in Oncology |
| Omar Abdel-Rahman | Aug-18 | Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease | Strahlentherapie und Onkologie |
| Hani Oweira, Anway Giryes, Meinrad Mannhart, Michael Decker, and Omar Abdel-Rahman | Aug-18 | Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials | Expert Review of Gastroenterology and Hepatology |
| Omar Abdel-Rahman | Aug-18 | Incidence and predictors of 1-year mortality among 9236 breast cancer patients referred for adjuvant chemotherapy | Future Oncology |
| Omar Abdel-Rahman | Jul-18 | Predictors of skeletal-related events among cancer patients with bone metastases treated with zoledronic acid: a secondary analysis of a randomized study | Expert Opinion on Drug Safety |
| Anway Giryes, Hani Oweira, Meinrad Mannhart, and Omar Abdel-Rahman | Jul-18 | Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer; a patient-level pooled analysis of two clinical trials | Expert Review of Gastroenterology and Hepatology |
| Teemu D. Laajala, Mika Murtojārvi, Arho Virkki, Tero Aittokalio | Jun-18 | ePCR: An R-package for Survival Time and Time-to-Event Prediction in Advanced Prostate Cancer, Applied to Real-World Patient Cohorts | Bioinformatics |
| Zhen Su, Monica M. Bertagnolli, A. Oliver Sartor, Catherine E. Symonds, Hao Zhang, Martin J. Murphy | Jun-18 | A novel, open-access data commons for improved disease management in patients (pts) with Merkel cell carcinoma (MCC) | Journal of Clinical Oncology |
| Omar Abdel-Rahman | Jun-18 | Patterns of on-treatment cardiac adverse events within three clinical trials of adjuvant anthracycline-based chemotherapy | Breast Cancer |
| Omar Abdel-Rahman | Jun-18 | Outcomes of early-stage breast cancer patients treated with sequential anthracyclines–taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial | Clinical and Translational Oncology |
| Junjie Hang, Lixia Wu, Lina Zhu, Khigiang Sun, Ge Wang, Jingjing Pan, Suhua Zheng, Kequn Xu, Jiadi Du, Hua Jiang | Jun-18 | Prediction of Overall Survival for Metastic Pancreatic Cancer: Development and Validation of a Prognostic Nomogram with Data from Open Clinical Trial and Real-World Study | Cancer Medicine |
| Zhen Su, Monica M. Bertagnolli, A. Oliver Sartor, Catherine E. Symonds, Hao Zhang, Martin J. Murphy | Jun-18 | A novel, open-access data commons for improved disease management in patients (pts) with Merkel cell carcinoma (MCC) | Journal of Clinical Oncology |
| Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan J. Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Tarek A. Hammad, Joann Lindenfeld, Martin J. Murphy, Javid Moslehi, On Behalf of the Checkpoint Inhibitor Safety Working Group | May-18 | Myocarditis Associated with Immune Checkpoint Inhibitors: an Expert Consensus on Data Gaps and a Call to Action | The Oncologist |
| Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Terek A. Hammad, Joann Lindenfeld, Martin J. Murphy, Javid Moslehi, On Behalf of the Checkpoint Inhibitor Safety Working Group | May-18 | Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action | The Oncologist |
| Patrick M. Cotogno, Lahiru K. Ranasinghe, Elisa M. Ledet, Brian E. Lewis, Oliver Sartor | Apr-18 | Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer | The Oncologist |
| Omar Abdel-Rahman | Apr-18 | Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials | The Breast |
| Omar Abdel-Rahman, Winson Y. Cheung | Apr-18 | Impact of smoking history on the outcomes of women with early-stage breast cancer: a secondary analysis of a randomized study | Medical Oncology |
| Omar Abdel-Rahman | Feb-18 | Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study | Journal of Cancer Research and Clinical Oncology |
| Omar Abdel-Rahman, Winson Y. Cheung | Jan-18 | External validation of the prostascore model inpatients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study | BJU International |
| Hitesh B. Mistry | Nov-17 | On the relationship between tumour growth rate and survival in non-small cell lung cancer | PeerJ |
| Massimiliano Zanin | Nov-17 | Using complex networks for refining survival prognosis in prostate cancer patient | F1000 Research |
| Detian Deng, Yu Du, Zhicheng Ji, Karthik Rao, Zhenke Wu, Yuxin Zhu, R. Yates Coley | Nov-17 | Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach | F1000 Research |
| Motoki Shiga | Nov-17 | Two-step feature selection for predicting survival time of patients with metastatic castrate resistant prostate cancer | F1000 Research |
| Soren Wengel Mogensen, Anne H. Petersen, Ann-Sophie Buchardt, Niels Richard Hansen | Nov-17 | Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patients | F1000 Research |
| S. Peter Wu, Moses Tam, Raymond Mailhot Vega, Carmen A. Perez, Naamit Kurshan Gerber | Nov-17 | Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up | Radiation Oncology |
| Sep-17 | Merck to co-lead new oncology big data alliance | PMLiVE | |
| Teemu D. Laajala, Justin Guinney, James C. Costello | Sep-17 | Community mining of open clinical trial data | Oncotarget |
| Karyn Hede | Aug-17 | Project Data Sphere to Make Cancer Clinical Trial Data Publicly Available | Journal of the National Cancer Institute |
| Fatemeh Seyednasrollah, Devin C. Koestler, Tao Wang, Stephen R. Piccolo, Roberto Vega, Russell Greiner, Christiane Fuchs, Eyal Gofer, Luke Kumar, Russell D. Wolfinger, Kimberly Kanigel Winner, Chris Bare, Elias Chaibub Neto, Thomas Yu, Liji Shen, Kald Abdallah, Thea Norman, Gustavo Stolovitzky, Howard R. Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I. Scher, Oliver Sartor, Laura L. Elo, Fang Liz Zhou, Justin Guinney, James C. Costello, and Prostate Cancer DREAM Challenge Community | Aug-17 | A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer | Journal of Clinical Oncology |
| Fatemeh Seyednasrollah, Devin C. Koestler, Tao Wang, Stephen R. Piccolo, Roberto Vega, Russell Greiner, Christine Fuchs, Eyal Gofer, Luke Kumar, Russell D. Wolfinger, Kimberly Kanigel Winner, Chris Bare, Elias Chaibub Neto, Thomas Yu, Liji Shen, Kald Abdallah, Thea Norman, Gustavo Stolovitzky, Howard R Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I Scher, Oliver Sartor, Laura L. Elo, Fang Liz Zhou, Justin Guinney, James C. Costello, Prostate Cancer DREAM Challenge Community | Aug-17 | A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer | JCO Clinical Cancer Informatics |
| Sebastian Pölsterl, Pankaj Gupta, Lichao Wang, Sailesh Conjeti, Amin Katouzian, Nassir Navab | Jul-17 | Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients | F1000 Research |
| Moses M. Tam, S. Peter Wu, Carmen Perez, Naamit Kurshan Gerber | Jul-17 | The effect of post-mastectomy radiation in women with one to three positive nodes enrolled on the control arm of BCIRG-005 at ten year follow-up | Radiotherapy and Oncology |
| Kald Abdallah, Charles Hugh-Jones, Thea Norman, Stephen Friend, Gustavo Stolovitzky | May-17 | The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer | The Oncologist |
| Ketan Patel, Mario Ouwens, Norah Shire, Sajan Khosla | May-17 | The application of electronic medical records (EMRs) as a virtual comparator arm in a lung cancer clinical trial: A case study | Journal of Clinical Oncology |
| Angela K. Green, Katherine E. Reeder-Hayes, Robert W. Corty, Ethan Basch, Mathew I. Milowsky, Stacie B. Dusetzina, Antonia V. Bennett, William A. Wood | May-17 | The Project Data Sphere Initiative: Accelerating Cancer Research by Sharing Data | The Oncologist |
| Monica M. Bertagnolli, Oliver Sartor, Bruce A. Chabner, Mace L. Rothenberg, Sean Khozin, Charles Hugh-Jones, David M. Reese, Martin J. Murphy | Mar-17 | Sounding Board: Advantages of a Truly Open-Access Data-Sharing Model | New England Journal of Medicine |
| Monica M. Bertagnolli, Oliver Sartor, Bruce A. Chabner, Mace L. Rothenberg, Sean Khozin, Charles Hugh-Jones, David M. Reese, Martin J. Murphy | Mar-17 | Sounding Board: Advantages of a Truly Open-Access Data-Sharing Model | New England Journal of Medicine |
| Bethany Pitcher, Leila Khoja, Robert J. Hamilton, Kald Abdallah, Melania Pintilie, Anthony M. Joshua | Feb-17 | Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. | PLOS ONE |
| Charles Hugh-Jones, Robin Jenkins, Joel Beetsch, Kald Abdallah, Michael Curnyn, Fang Liz Zhou, Mace L. Rothenberg, Gregory A. Curt, John Dornan, Martin J. Murphy | Jan-17 | Overcoming barriers to develop a broad access data sharing platform | Journal of Clinical Oncology |
| Charles Hugh-Jones, Robin Jenkins, Joel Beetsch, Kald Abdallah, Michael Curnyn, Fang Liz Zhou, Mace L. Rothenberg, Gregory A. Curt, John Dornan, Martin J. Murphy | Jan-17 | Overcoming barriers to develop a broad access data sharing platform | Journal of Clinical Oncology |
| Wenjuan Mei, Anil Kapoor, Pierre Major, Bobby Shayegan, Damu Tang | Jan-17 | Progress towards accurate prediction of overall survival in men with metastatic castration-resistant prostate cancer | Journal of Xiangya Medicine |
| Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, Greg Curt, Mace Rothenberg, Ronit Simantov, Martin Murphy, Joseph Morrell, Joel Beetsch, Daniel J. Sargent, Howard I. Scher, Peter Lebowitz,, Richard Simon, Wilfred D. Stein, Susan E. Bates, Tito Fojo | Jan-17 | Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis | The Lancet Oncology |
| Justin Guinney, Tao Wang, Teemu D. Laajala, Kimberly Kanigel Winner, J. Christopher Bare, Elias Chaibub Neto, Suleiman A. Khan, Gopal Peddinti, Antti Airola, Tapio Pahkkala, Tuomas Mirtti, Thomas Yu, Brian M. Bot, Liji Shen, Kald Abdallah, Thea Norman, Stephen Friend, Gustavo Stolovitzky, Howard Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I. Scher, Oliver Sartor, Yang Xie, Tero Aittokallio, Fang Liz Zhou, James C. Costello | Jan-17 | Prediction of Overall Survival for Patients with Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge with Open Clinical Trial Data | The Lancet Oncology |
| Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, Greg Curt, Mace Rothenberg, Ronit Simantov, Martin Murphy, Joseph Morrell, Joel Beetsch, Daniel J. Sargent, Howard I. Scher, Peter Lebowitz, Richard Simon, Wilfred D. Stein, Susan E. Bates, Tito Fojo | Dec-16 | Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A retrospective Analysis | Lancet Oncology |
| Justin Guinney, Tao Wang, Teemu D Laajala, Kimberly Kanigel Winner, J. Christopher Bare, Elias Chaibub Neto, Suleiman A. Khan, Gopal Peddinti, Antti Airola, Tapio Pahikkala, Tuomas Mirtti, Thomas Yu, Brian M. Bot, Liji Shen, Kald Abdallah, Thea Norman, Stephen Friend, Gustavo Stolovitzky, Howard Soule, Christopher J. Sweeney, Charles J Ryan, Howard I Scher, Oliver Sartor, Yang Xie, Tero Aitokallio, Fang Liz Zhou, James C. Costello | Nov-16 | Prediction of Overall Survival for Patients with Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge with Open Clinical Trial Data | Lancet Oncology |
| H-G Eichler, B. Bloechl-Daum, P. Bauer, F. Bretz, J. Brown, LV Hampson, P. Honig, M. Krams, H. Leufkens, R. Lim, M.M. Lumpkin, M.J. Murphy, F. Pignatti, M. Posch, S. Schneeweiss, M. Trusheim, F. Koenig | Oct-16 | "Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials? | Clinical Pharmacology & Therapeutics |
| H-G Eichler, B Bloechl-Daum, P Bauer, F Bretz, J Brown, LV Hampson, P Honig, M Krams, H Leufkens, R Lim, MM Lumpkin, MJ Murphy, F Pignatti, M Posch, S Schneeweiss, M Trusheim, F Koenig | Sep-16 | “Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials? | Clinical Pharmacology & Therapeutics |
| Guru Sonpavdea, Gregory R.Pond, Arnoud J.Templeton, Abderrahim Fandi, Bertrand Tombale, Mark Rosenthal, Andrew J.Armstrong, Daniel P.Petrylakh | Jun-16 | Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel | European Urology |
| N. Geifman, A.J Butte | May-16 | A Patient-Level Data Meta-Analysis of Standard-of-Care Treatments from Eight Prostate Cancer Clinical Trials | Nature Scientific Data |
| Daniel E. Spratt, Yu-Wei Chen, Brandon A. Mahal, Joseph R. Osborne, Shuang G. Zhao, Todd M. Morgan, Ganesh Palapattu, Felix Y. Feng, Paul L. Nguyen | Mar-16 | Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes | European Urology |
| Thierry Wendling, Hitesh Mistry, Kayode Ogungbenro, Leon Aarons | Mar-16 | Predicting Survival of Pancreatic Cancer Patients Treated with Gemcitabine Using Longitudinal Tumour Size Data | Cancer Chemotherapy and Pharmacology |
| Kald Abdallah, Charles Hugh-Jones, Thea Norman, Stephen Friend, Gustavo Stolovitzky | May-15 | The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer | The Oncologist |
| Angela K. Green, Robert W. Corty, William A. Wood, Mathew Meeneghan, Katherine E. Reeder-Hayes, Ethan Basch, Matthew I Milowsky, Stacie B. Dusetzina | May-15 | Comparative Effectiveness of Mitoxantrone plus Prednisone versus Prednisone alone in Metastatic Castrate-resistant Prostate Cancer after Docetaxel Failure | The Oncologist |